Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Change in Account Payables (2016 - 2025)

AtriCure (ATRC) has disclosed Change in Account Payables for 16 consecutive years, with -$1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 77.9% to -$1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$960000.0, a 37.3% increase, with the full-year FY2025 number at -$960000.0, up 37.3% from a year prior.
  • Change in Account Payables was -$1.3 million for Q4 2025 at AtriCure, down from $360000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $4.2 million in Q3 2024 to a low of -$5.8 million in Q4 2024.
  • A 5-year average of $553650.0 and a median of $846000.0 in 2021 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: plummeted 1738.25% in 2022, then soared 253.49% in 2024.
  • AtriCure's Change in Account Payables stood at $183000.0 in 2021, then tumbled by 1738.25% to -$3.0 million in 2022, then surged by 167.71% to $2.0 million in 2023, then plummeted by 384.24% to -$5.8 million in 2024, then skyrocketed by 77.9% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Change in Account Payables are -$1.3 million (Q4 2025), $360000.0 (Q3 2025), and $677000.0 (Q2 2025).